PT-141 Peptide: What It Is, How It Works, and What to Know

PT-141 peptide, also called bremelanotide, is a prescription melanocortin receptor agonist approved by the FDA as Vyleesi for premenopausal women with hypoactive sexual desire disorder (HSDD). It is given as a 1.75 mg subcutaneous injection and works on the brain's melanocortin system rather than on blood flow. PT-141 is not approved for men, is not a Viagra-style vasodilator, and is not legally sold as a nasal spray or as a research chemical for human use.

What Is PT-141 Peptide?

PT-141 is a synthetic peptide developed from melanotan II, a compound originally studied for tanning. During early trials, participants reported unexpected increases in sexual desire, so researchers modified the molecule to emphasize that effect.

Bremelanotide binds melanocortin receptors MC3R and MC4R in the hypothalamus, a brain region involved in appetite, mood, and sexual response. That central mechanism is what separates PT-141 from drugs that act on blood vessels.

PT-141 is available only by prescription in the United States. The FDA approved it in 2019 for HSDD in premenopausal women.

How PT-141 Works Compared With Other Options

Because PT-141 acts on the brain rather than on circulation, it does not require sexual stimulation to start working the way sildenafil does. It also does not carry the same nitrate interaction warning that limits PDE5 inhibitors.

Feature	PT-141 (bremelanotide)	PDE5 inhibitors	Testosterone therapy
Primary target	Melanocortin receptors in the brain	Blood flow in the genitals	Hormone levels
FDA-approved use	HSDD in premenopausal women	Erectile dysfunction	Low testosterone
Route	Subcutaneous injection	Oral tablet	Injection, gel, or patch
Typical onset	30 to 60 minutes	30 to 60 minutes	Weeks to months
Common side effects	Nausea, flushing, headache	Headache, flushing, stuffy nose	Acne, mood changes, raised red blood cell count

PT-141 for Men: What the Research Shows

PT-141 is not FDA-approved for men. Small trials tested bremelanotide in men with erectile dysfunction who did not respond to sildenafil, and the results were modest and inconsistent.

Because of that gap, many men look into pt-141 peptide for men through forums and gray-market vendors instead of through a clinician. That route carries real risk, including unverified purity, incorrect dosing, and no medical monitoring.

Men with desire or erection concerns have several FDA-approved options, and a urologist can help match the right one. PT-141 should not be used as a first-line treatment in men outside a research setting.

Dosage, Timing, and How Long PT-141 Lasts

The manufacturer's pt-141 peptide dosage chart lists one fixed dose: 1.75 mg injected under the skin of the abdomen or thigh. Do not exceed one dose in 24 hours or eight doses in a month.

Patients often ask pt-141 peptide how long does it last before planning an evening around a dose. Effects usually begin within 30 to 60 minutes and fade over roughly two to three hours, though individual responses vary.

There is no titration schedule to adjust for body weight or response, because the approved dose is the same for everyone. Anyone who has severe nausea, persistent vomiting, or a blood pressure spike should not take another dose without speaking to a clinician.

Nasal Spray and Other Forms

An earlier pt-141 peptide nasal spray was tested in clinical trials but was never approved in the United States. Researchers set it aside because absorption varied widely between users and some participants had sharp rises in blood pressure.

Today, bremelanotide is only legally available as a single-use autoinjector pen. Products sold as PT-141 nasal spray, capsules, or loose powder are unapproved and may contain unknown ingredients or inaccurate amounts of the drug.

Side Effects and Safety

Nausea is the most commonly reported side effect, affecting roughly 40% of participants in clinical trials. Other effects include flushing, headache, and reactions at the injection site.

• Nausea and vomiting
• Flushing and a sensation of warmth
• Headache
• Injection site pain, bruising, or swelling
• Short-term increases in blood pressure
• Focal hyperpigmentation, or dark patches on the skin, gums, or breasts, with repeated use

Bremelanotide can raise blood pressure for several hours after a dose. People with uncontrolled hypertension or known cardiovascular disease should not use PT-141.

Because focal hyperpigmentation appears to be cumulative, anyone using PT-141 regularly should watch for skin and gum changes and report them to a prescriber.

PT-141 is not recommended during pregnancy, and it may interact with other medications that affect blood pressure. Disclose all prescriptions and supplements to a healthcare professional before starting treatment.

Cost, Availability, and What to Avoid

Vyleesi is dispensed only by prescription, so the only legitimate pt-141 peptide price is what a pharmacy or specialty distributor charges. Insurance coverage varies, and many plans require prior authorization for HSDD treatment.

Listings advertised as research chemicals are not the same product as the approved drug. They are not tested for purity or sterility, and injecting them carries infection and dosing risks.

The Bottom Line

PT-141 is a real, FDA-approved drug with a narrow approved use, but it is widely misrepresented online as a general libido booster.

PT-141 is FDA-approved only for premenopausal women with hypoactive sexual desire disorder.

PT-141 does not work like Viagra because it targets melanocortin receptors in the brain rather than blood flow.

There is no FDA-approved PT-141 nasal spray available in the United States.

Anyone considering PT-141 should speak with a healthcare professional instead of buying unapproved peptides online.

COMMON QUESTIONS

Frequently Asked Questions

Is PT-141 FDA-approved?

Yes, but only in a narrow way. Bremelanotide is approved as Vyleesi for premenopausal women diagnosed with hypoactive sexual desire disorder, given as a 1.75 mg subcutaneous injection. It is not approved for men, for general libido enhancement, or as an over-the-counter product.

How long does PT-141 last?

The effects of a PT-141 injection typically begin within 30 to 60 minutes and fade over about two to three hours. The drug is limited to one dose every 24 hours and no more than eight doses per month. Individual response times can vary.

Can you buy PT-141 peptide online?

Pharmaceutical-grade PT-141 requires a prescription, so legitimate sales go through pharmacies and specialty distributors rather than general online marketplaces. Powders and sprays marketed as research chemicals are unapproved, untested for purity, and not intended for human use.